Prime Medicine
Jeffery Jones has a diverse work experience in the field of molecular biology and research and development. Jeffery is currently working as a Scientist in Molecular Biology - Vector Engineering at Prime Medicine, Inc. since July 2021. Prior to that, they served as an Associate Scientist II at Dyno Therapeutics from August 2020 to July 2021. Jeffery also worked at Intellia Therapeutics, Inc. as a Scientist, Platform Development from January 2020 to August 2020, and as a Senior Associate Scientist, Molecular Biology from August 2018 to January 2020.
Before joining Intellia Therapeutics, they worked at Advaxis, Inc. in various roles including Senior Scientist, Research and Development from July 2017 to August 2018, Scientist II, Research and Development from June 2016 to July 2017, and Associate, Research and Development from July 2015 to June 2016. Jeffery's earlier experience includes working as a Research Assistant III at Cincinnati Children's Hospital Medical Center Department of Developmental Biology from July 2014 to July 2015.
Jeffery gained research experience through their volunteer work at Baylor College of Medicine i5K (insect 5000 genomes) initiative from 2014 to 2015, International Glossina Genome Initiative from 2012 to 2014, and as a Graduate Researcher at Oakland University Department of Biological Sciences from 2012 to 2014. Jeffery also worked as a Teaching Assistant/Instructor at Oakland University Department of Biological Sciences during the same period.
Jeffery'scareer in research began as a Post Baccalaureate Researcher at Wayne State University from 2011 to 2012. Overall, Jeffery Jones has gained a breadth of experience in the molecular biology field, specializing in vector engineering and platform development.
Jeffery Jones obtained a Bachelor of Science (B.Sc.) in Biology, General from Wayne State University in 2011. Jeffery then pursued a Master of Science (M.S.) in Molecular Biology at Oakland University, which they completed in 2014.
This person is not in the org chart
This person is not in any offices
Prime Medicine
4 followers
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.